A dynamic in-vitro model of the intestinal epithelium for the investigation of P-glycoprotein activity
暂无分享,去创建一个
A. Ahluwalia | S. Rapposelli | J. Costa | Daniele Poli | Vanessa Almonti | L. Cacopardo | Joana Costa
[1] J. Costa,et al. Real-time cellular impedance monitoring and imaging of biological barriers in a dual-flow membrane bioreactor. , 2019, Biosensors & bioelectronics.
[2] X. Illa,et al. Engineering and monitoring cellular barrier models , 2018, Journal of Biological Engineering.
[3] H. Hsieh,et al. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer , 2017, Scientific Reports.
[4] B. Aggarwal,et al. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. , 2017, Clinical science.
[5] Caroline C. O'Brien,et al. Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Daniele Mazzei,et al. Environmental Control in Flow Bioreactors , 2017 .
[7] Jong-ryul Choi,et al. Localized Down-regulation of P-glycoprotein by Focused Ultrasound and Microbubbles induced Blood-Brain Barrier Disruption in Rat Brain , 2016, Scientific Reports.
[8] H. Walles,et al. Development of an Advanced Primary Human In Vitro Model of the Small Intestine. , 2016, Tissue engineering. Part C, Methods.
[9] Mandy B. Esch,et al. TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.
[10] C. Cho,et al. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[11] Claudio Domenici,et al. A novel dual‐flow bioreactor simulates increased fluorescein permeability in epithelial tissue barriers , 2014, Biotechnology journal.
[12] Arti Ahluwalia,et al. Design Criteria for Generating Physiologically Relevant In Vitro Models in Bioreactors , 2014 .
[13] A. Lamprecht,et al. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] R. Perrone,et al. SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity. , 2014, European journal of medicinal chemistry.
[15] S. Andreadis,et al. Differential and synergistic effects of mechanical stimulation and growth factor presentation on vascular wall function. , 2013, Biomaterials.
[16] J. Kanwar,et al. Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model , 2013, Journal of cancer science & therapy.
[17] Lei Li,et al. Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo , 2013, Clinics.
[18] L. Benet,et al. Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements , 2013, The AAPS Journal.
[19] E. Kennelly,et al. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. , 2012, Journal of medicinal food.
[20] S. Cisternino,et al. Heterogeneity in the Rat Brain Vasculature Revealed by Quantitative Confocal Analysis of Endothelial Barrier Antigen and P-Glycoprotein Expression , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] Katja Schenke-Layland,et al. The physiological performance of a three-dimensional model that mimics the microenvironment of the small intestine. , 2011, Biomaterials.
[22] S. Ki,et al. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. , 2011, Biopharmaceutics & drug disposition.
[23] N. Piyapolrungroj,et al. Effects of Curcuma spp. on P-glycoprotein function. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[24] Jean-Pierre Gillet,et al. Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.
[25] H. Lage. An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.
[26] J. Azuma,et al. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. , 2008, International journal of pharmaceutics.
[27] F. Berardi,et al. Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. , 2008, Journal of medicinal chemistry.
[28] A. Paradiso,et al. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. , 2008, Bioorganic & medicinal chemistry.
[29] Olivier Fardel,et al. Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR , 2007, Fundamental & clinical pharmacology.
[30] F. Berardi,et al. Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition. , 2006, Journal of medicinal chemistry.
[31] A. Andriulli,et al. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. , 2006, World journal of gastroenterology.
[32] Brian P Helmke,et al. Mechanisms of mechanotransduction. , 2006, Developmental cell.
[33] S. Kitagawa,et al. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. , 2005, Biochemical and biophysical research communications.
[34] Andreas Janshoff,et al. Automated multi-well device to measure transepithelial electrical resistances under physiological conditions. , 2004, BioTechniques.
[35] R. Borchardt,et al. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. , 2004, Journal of pharmaceutical sciences.
[36] R. Conradi,et al. Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa , 1990, Pharmaceutical Research.
[37] J. Satsangi,et al. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? , 2003, Gut.
[38] H. Coley,et al. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.
[39] J. P. Fawcett,et al. The involvement of P-glycoprotein in berberine absorption. , 2002, Pharmacology & toxicology.
[40] L. Benet,et al. The drug efflux-metabolism alliance: biochemical aspects. , 2001, Advanced drug delivery reviews.
[41] M. Pirmohamed,et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. , 2001, Clinical Cancer Research.
[42] M. Balda,et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.
[43] P. Twentyman,et al. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. , 1994, European journal of cancer.
[44] Thomas J. Raub,et al. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.